1. Transdermal Scopolamine for Prevention of Motion Sickness
2. FDA Drug Safety Communication: FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.https://web.archive.org/web/20090307042455/http://www.fda.gov/cder/drug/advisory/transdermalpatch.htm. Archived from the original on January 18 2017
3. Toxic Leukoencephalopathy Due to Transdermal Fentanyl Overdose
4. FDA Public Health Advisory: Risk of burns during MRI scans from transdermal drug patches with metallic backing.https://web.archive.org/web/20090307042455/http://www.fda.gov/cder/drug/advisory/transdermalpatch.htm. Archived from the original on January 18 2017
5. Analgesic patches and defibrillators: a cautionary tale